| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(13)62418-6 |
| P698 | PubMed publication ID | 24954674 |
| P50 | author | Maria Stamelou | Q64856626 |
| David Burn | Q30500735 | ||
| Kailash Phatechand Bhatia | Q42862244 | ||
| P2093 | author name string | David J Burn | |
| Jose A Obeso | |||
| Maria C Rodriguez-Oroz | |||
| P2860 | cites work | Parkinson's disease motor subtypes and mood | Q48787563 |
| From Jekyll to Hyde after limbic subthalamic nucleus infarction | Q49133160 | ||
| Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study | Q50792593 | ||
| Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study | Q51736046 | ||
| Neuropsychiatric aspects of treated Wilson's disease. | Q51867020 | ||
| Frontal presentation in progressive supranuclear palsy | Q51900314 | ||
| Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study | Q51967426 | ||
| Cognitive profile of patients with newly diagnosed Parkinson disease | Q51987773 | ||
| PROGRESSIVE LENTICULAR DEGENERATION: A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVER | Q55921805 | ||
| Motor control in basal ganglia circuits using fMRI and brain atlas approaches | Q81694631 | ||
| Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine | Q84667839 | ||
| C9orf72 repeat expansions are a rare genetic cause of parkinsonism | Q23936600 | ||
| Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia | Q24297970 | ||
| De novo mutations in ATP1A3 cause alternating hemiplegia of childhood | Q24600468 | ||
| The non-motor syndrome of primary dystonia: clinical and pathophysiological implications | Q27012793 | ||
| Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa? | Q27687503 | ||
| Mutation in the alpha-synuclein gene identified in families with Parkinson's disease | Q27860459 | ||
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus | Q28299834 | ||
| Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex | Q29391304 | ||
| The functional anatomy of basal ganglia disorders | Q29617461 | ||
| Primate models of movement disorders of basal ganglia origin | Q29618489 | ||
| Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency | Q30419465 | ||
| Social cognitive deficits and their neural correlates in progressive supranuclear palsy. | Q30466418 | ||
| Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. | Q30498096 | ||
| Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration | Q30503638 | ||
| JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family | Q30515533 | ||
| PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine | Q30528874 | ||
| C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism | Q30529336 | ||
| Genetics of dystonia: what's known? What's new? What's next? | Q33356255 | ||
| Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients | Q33574373 | ||
| THAP1 mutations (DYT6) are an additional cause of early-onset dystonia | Q33730350 | ||
| Switching from automatic to controlled behavior: cortico-basal ganglia mechanisms | Q33763015 | ||
| Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship. | Q34022505 | ||
| The link between the GBA gene and parkinsonism | Q34077492 | ||
| Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging | Q34102325 | ||
| Recent advances in the genetics of Parkinson's disease | Q34189660 | ||
| Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system | Q34248307 | ||
| Screening for impulse control symptoms in patients with de novo Parkinson disease | Q34538553 | ||
| A systematic review of prevalence studies of depression in Parkinson's disease | Q34711370 | ||
| The neuropathological basis for depression in Parkinson's disease | Q34764454 | ||
| Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. | Q35776914 | ||
| Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease. | Q35888638 | ||
| Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. | Q35906678 | ||
| Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. | Q35973431 | ||
| Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study | Q36341411 | ||
| The genetics of Parkinson's disease: Progress and therapeutic implications | Q36626825 | ||
| Contributions of the basal ganglia and functionally related brain structures to motor learning | Q37343131 | ||
| The behavioral spectrum of Gilles de la Tourette syndrome | Q37440272 | ||
| Prospective cohort study of impulse control disorders in Parkinson's disease. | Q37490160 | ||
| Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. | Q37631957 | ||
| Psychiatric disorders, myoclonus dystonia, and the epsilon‐sarcoglycan gene: A systematic review | Q37895597 | ||
| Biological markers of cognition in prodromal Huntington's disease: a review. | Q37926008 | ||
| Psychosis, apathy, depression and anxiety in Parkinson's disease | Q37975845 | ||
| Lysosome-dependent pathways as a unifying theme in Parkinson's disease. | Q38038561 | ||
| The functional anatomy of Gilles de la Tourette syndrome | Q38067192 | ||
| Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease? | Q38085592 | ||
| "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide | Q38110488 | ||
| Future of brain stimulation: new targets, new indications, new technology | Q38152385 | ||
| Cognition and psychopathology in myoclonus-dystonia. | Q38470964 | ||
| The endophenotype and the phenotype: temporal discrimination and adult-onset dystonia | Q39336444 | ||
| Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders | Q39482245 | ||
| Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia | Q40098504 | ||
| The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease | Q40630408 | ||
| Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Q42495577 | ||
| Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease | Q42830127 | ||
| Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling | Q43118608 | ||
| The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study | Q44171532 | ||
| Parkin disease: a phenotypic study of a large case series | Q44451919 | ||
| Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes | Q45289325 | ||
| Nonmotor symptoms in Parkin gene-related parkinsonism. | Q45900021 | ||
| Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours | Q47895602 | ||
| Autonomic failures in Perry syndrome with DCTN1 mutation | Q48093099 | ||
| Effects of transient inactivation of the subthalamic nucleus by local muscimol and APV infusions on performance on the five-choice serial reaction time task in rats. | Q48287745 | ||
| The striatum and probabilistic implicit sequence learning | Q48307250 | ||
| FXTAS: new insights and the need for revised diagnostic criteria | Q48331490 | ||
| The subthalamic nucleus is involved in successful inhibition in the stop-signal task: a local field potential study in Parkinson's disease | Q48377990 | ||
| The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture | Q48543386 | ||
| P433 | issue | 9942 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 523-531 | |
| P577 | publication date | 2014-06-18 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | The expanding universe of disorders of the basal ganglia | |
| P478 | volume | 384 |
| Q90727622 | A Multilevel Computational Characterization of Endophenotypes in Addiction |
| Q36020733 | A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease |
| Q90451873 | Abnormalities of intrinsic regional brain activity in first-episode and chronic schizophrenia: a meta-analysis of resting-state functional MRI |
| Q92616934 | Agenesis of the putamen and globus pallidus caused by recessive mutations in the homeobox gene GSX2 |
| Q45305432 | Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study. |
| Q36073720 | Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial |
| Q33819387 | Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior |
| Q34452721 | Clinical spectrum of levodopa-induced complications |
| Q42650189 | Cross-Cutting Advancements Usher in a New Era for Motor Research in Psychosis |
| Q87945516 | Cyclic AMP-producing chemogenetic activation of indirect pathway striatal projection neurons and the downstream effects on the globus pallidus and subthalamic nucleus in freely moving mice |
| Q60047141 | Defending the Body Without Sensing the Body Position: Physiological Evidence in a Brain-Damaged Patient With a Proprioceptive Deficit |
| Q58715423 | Distinctive tics suppression network in Gilles de la Tourette syndrome distinguished from suppression of natural urges using multimodal imaging |
| Q45071393 | Dopamine Modulates Serotonin Innervation in the Drosophila Brain |
| Q37274056 | Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease. |
| Q47277130 | Emotion Recognition Correlates With Social-Neuropsychiatric Dysfunction in Huntington's Disease. |
| Q91899116 | Enhanced baseline activity in the left ventromedial putamen predicts individual treatment response in drug-naive, first-episode schizophrenia: Results from two independent study samples |
| Q47121220 | Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease |
| Q55069615 | Experimental Intrastriatal Applications of Botulinum Neurotoxin-A: A Review. |
| Q41916431 | GABAA receptor activity shapes the formation of inhibitory synapses between developing medium spiny neurons. |
| Q90721981 | Instrument-based assessment of motor function yields no evidence of dyskinesia in adult first-degree biological relatives of individuals with schizophrenia and schizoaffective disorder |
| Q97883260 | Lateralized Deficits of Disgust Processing After Insula-Basal Ganglia Damage |
| Q56967259 | Localizing parkinsonism based on focal brain lesions |
| Q48150161 | MP2RAGE for deep gray matter measurement of the brain: A comparative study with MPRAGE. |
| Q64767203 | MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway |
| Q35233611 | Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's disease. |
| Q47621817 | Motor Abnormalities: From Neurodevelopmental to Neurodegenerative Through "Functional" (Neuro)Psychiatric Disorders |
| Q89959086 | Motor abnormalities and basal ganglia in first-episode psychosis (FEP) |
| Q57494356 | Motor clusters reveal differences in risk for psychosis, cognitive functioning, and thalamocortical connectivity: evidence for vulnerability subtypes |
| Q38332389 | Movement disorders and psychosis, a complex marriage |
| Q37263797 | Parkinson's Disease and Cryptogenic Epilepsy |
| Q38894971 | Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists |
| Q28080503 | Parkinson's disease: animal models and dopaminergic cell vulnerability |
| Q53442110 | Pathophysiology of dyskinesia and behavioral disorders in non-human primates: the role of serotonergic fibers |
| Q41850803 | Patients with schizophrenia show aberrant patterns of basal ganglia activation: Evidence from ALE meta-analysis |
| Q27011417 | Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease |
| Q64903283 | Protection of tissue physicochemical properties using polyfunctional crosslinkers. |
| Q64076350 | Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study |
| Q47987829 | Relationship between aging and T1 relaxation time in deep gray matter: A voxel-based analysis |
| Q42509341 | Selective neuronal expression of the SoxE factor, Sox8, in direct pathway striatal projection neurons of the developing mouse brain. |
| Q38668648 | Structural connectivity differences in essential tremor with and without resting tremor |
| Q48252241 | Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease |
| Q47317693 | Synaptic regulator α-synuclein in dopaminergic fibers is essentially required for the maintenance of subependymal neural stem cells. |
| Q47547751 | Systems Neuroscience of Psychosis: Mapping Schizophrenia Symptoms onto Brain Systems |
| Q52150513 | The changing tree in Parkinson's disease |
| Q48391042 | The neuropsychological profile of children with basal ganglia encephalitis: a case series |
| Q39208290 | The use of nonhuman primate models to understand processes in Parkinson's disease. |
| Q60445929 | The utility of an RDoC motor domain to understand psychomotor symptoms in depression |
| Q47639157 | Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females |
| Q38478999 | Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future |
| Q27322756 | Ultra-High Field MRI Post Mortem Structural Connectivity of the Human Subthalamic Nucleus, Substantia Nigra, and Globus Pallidus |
| Q51767167 | Value encoding in the globus pallidus: fMRI reveals an interaction effect between reward and dopamine drive |
| Q38407496 | Verbal fluency as a function of time in autism spectrum disorder: An impairment of initiation processes? |
| Q47269977 | What Can Different Motor Circuits Tell Us About Psychosis? An RDoC Perspective |
| Q37065672 | γ-Aminobutyric Acid Type A (GABAA) Receptor Subunits Play a Direct Structural Role in Synaptic Contact Formation via Their N-terminal Extracellular Domains. |
Search more.